Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Feb 4:9:44.
doi: 10.1186/1748-717X-9-44.

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance

Joen Sveistrup  1 , Per Munck af Rosenschöld, Joseph O Deasy, Jung Hun Oh, Tobias Pommer, Peter Meidahl Petersen, Svend Aage Engelholm
Affiliations
Comparative Study

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance

Joen Sveistrup et al. Radiat Oncol. .

Abstract

Background: Image-guided radiotherapy (IGRT) facilitates the delivery of a very precise radiation dose. In this study we compare the toxicity and biochemical progression-free survival between patients treated with daily image-guided intensity-modulated radiotherapy (IG-IMRT) and 3D conformal radiotherapy (3DCRT) without daily image guidance for high risk prostate cancer (PCa).

Methods: A total of 503 high risk PCa patients treated with radiotherapy (RT) and endocrine treatment between 2000 and 2010 were retrospectively reviewed. 115 patients were treated with 3DCRT, and 388 patients were treated with IG-IMRT. 3DCRT patients were treated to 76 Gy and without daily image guidance and with 1-2 cm PTV margins. IG-IMRT patients were treated to 78 Gy based on daily image guidance of fiducial markers, and the PTV margins were 5-7 mm. Furthermore, the dose-volume constraints to both the rectum and bladder were changed with the introduction of IG-IMRT.

Results: The 2-year actuarial likelihood of developing grade > = 2 GI toxicity following RT was 57.3% in 3DCRT patients and 5.8% in IG-IMRT patients (p < 0.001). For GU toxicity the numbers were 41.8% and 29.7%, respectively (p = 0.011). On multivariate analysis, 3DCRT was associated with a significantly increased risk of developing grade > = 2 GI toxicity compared to IG-IMRT (p < 0.001, HR = 11.59 [CI: 6.67-20.14]). 3DCRT was also associated with an increased risk of developing GU toxicity compared to IG-IMRT.The 3-year actuarial biochemical progression-free survival probability was 86.0% for 3DCRT and 90.3% for IG-IMRT (p = 0.386). On multivariate analysis there was no difference in biochemical progression-free survival between 3DCRT and IG-IMRT.

Conclusion: The difference in toxicity can be attributed to the combination of the IMRT technique with reduced dose to organs-at-risk, daily image guidance and margin reduction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of the actuarial likelihood of developing a grade ≥2 GI and GU toxicity, respectively, during a 2-year follow-up between patients treated with 3DCRT and IG-IMRT.
Figure 2
Figure 2
Comparison of the actuarial likelihood of developing biochemical relapse between patients treated with 3DCRT and IG-IMRT.
Figure 3
Figure 3
Left: Treatment plan for 3DCRT (2 cm PTV margin). Right: Treatment plan for fixed-angle IMRT (5–7 mm PTV margin).
See this image and copyright information in PMC

References

    1. Mottet N, Peneau M, Mazeron JJ. et al.Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial. Eur Urol. 2012;62(2):213–219. doi: 10.1016/j.eururo.2012.03.053. - DOI - PubMed
    1. Martin JM, Bayley A, Bristow R. et al.Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol. 2009;4:50. doi: 10.1186/1748-717X-4-50. 10.1186/1748-717×−4-50. - DOI - PMC - PubMed
    1. Gill S, Thomas J, Fox C. et al.Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol. 2011;6:145. doi: 10.1186/1748-717X-6-145. 10.1186/1748-717×−6-145. - DOI - PMC - PubMed
    1. Zelefsky MJ, Kollmeier M, Cox B. et al.Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;84(1):125–129. doi: 10.1016/j.ijrobp.2011.11.047. - DOI - PubMed
    1. Engels B, Soete G, Verellen D. et al.Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys. 2009;74(2):388–391. doi: 10.1016/j.ijrobp.2008.08.007. - DOI - PubMed

Publication types

MeSH terms